TP53 and myelodysplastic syndrome: Among patients with MDS-RS, the frequency of complex karyotypes and the TP53 mutation rate were significantly lower in the MDS-E group than in the MDS-NE group(0 vs 11.9%, P=0.048 and 2.4% vs 15.1%, P=0.053, respectively).